Notice NOT-HD-23-003 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-070 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-24-027 from the NIH Guide for Grants and Contracts. This concept proposes to advance methodological rigor in NIDA-relevant research by supporting training on the responsible analyses of complex, large-scale datasets involving brain, behavioral, genomic, and socioenvironmental data through: 1. Courses for Skills Development 2. Curriculum or Methods Development

Notice NOT-OD-23-080 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-037 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-036 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-035 from the NIH Guide for Grants and Contracts

Notice NOT-MH-23-185 from the NIH Guide for Grants and Contracts

Notice NOT-MH-23-186 from the NIH Guide for Grants and Contracts

Notice NOT-MH-23-190 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-042 from the NIH Guide for Grants and Contracts

Notice NOT-HG-23-020 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-042 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-090 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications for multi-center clinical trials focused on neurological emergencies. Successful applicants will collaborate and conduct the trial within the NIH SIREN Network. The NIH SIREN Clinical Coordinating Center (CCC) will work with the successful applicants to implement the proposed trial efficiently and the SIREN Data Coordinating Center (DCC) will provide statistical and data management support. The NIH SIREN hubs and their affiliated clinical sites will provide on-site implementation of the clinical protocols.The NIH SIREN Network will also be uniquely poised to collaborate with other US and international consortia necessary to conduct larger, definitive trials of promising interventions for neurological emergencies. Multi-center clinical trials in stroke treatment, recovery, or prevention supported by NINDS will be conducted in the NIH StrokeNet, and not within SIREN. Applicants do not need to be part of the existing SIREN infrastructure to apply under this FOA.

Funding Opportunity RFA-DK-22-511 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from the two previously funded Rare and Atypical DIAbetes NeTwork (RADIANT) research centers to further study rare and atypical forms of diabetes mellitus. These centers will continue to identify and analyze phenotypic and genotypic defects that may provide insights into more common, heterogeneous forms of diabetes mellitus in the general population. RADIANT will also continue to develop community resources to advance research in this area through the collection and dissemination of data and samples for access by the broad research community. During this grant cycle, RADIANT will establish precision diagnoses for new Mendelian forms of diabetes by enrolling family members of previously enrolled participants with a family history suggestive of a Mendelian form of diabetes to aid in identifying potential causal variants. In addition, in vitro and basic studies leveraging induced pleuripotent stem cells (iPSCs) differentiated into tissues of interest will be used to establish pathogenicity of potential causal variants.

Funding Opportunity RFA-DA-24-037 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV.

Notice NOT-DK-23-012 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-22-077 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Leadership Center of the NIAID Consortium for Food Allergy Research (CoFAR). The CoFAR Leadership Center (LC) will define the overall research strategy of the CoFAR including design and oversight of cutting-edge clinical trials and clinical studies to advance prevention and management strategies and to improve knowledge on the origins and the pathophysiology of IgE-mediated food allergy, Alpha-Gal Syndrome, Food Protein-Induced Enterocolitis Syndrome, and Eosinophilic Esophagitis. To achieve its objectives, the CoFAR-LC will work closely and collaborate with the CoFAR Clinical Research Centers (CRCs) to select and implement all CoFAR network-wide clinical trials and studies. The CoFAR-CRCs will be responsible for execution of the CoFAR network-wide clinical trials and studies.

Funding Opportunity RFA-AI-22-076 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Clinical Research Centers (CRC) for the NIAID Consortium for Food Allergy Research (CoFAR). The CoFAR-CRCs will conduct both network-wide observational studies/clinical trials and center-specific projects with the goals to advance prevention and management strategies and to improve knowledge on the origins and the pathophysiology of IgE-mediated food allergy, Alpha-Gal Syndrome, Food Protein-induced Enterocolitis Syndrome and Eosinophilic Esophagitis. For network-wide clinical research projects and other network functions, the CoFAR-CRCs will work closely with the CoFAR Leadership Center (CoFAR-LC). The CoFAR CRCs also will conduct center-specific human research projects.

Notice NOT-CA-23-043 from the NIH Guide for Grants and Contracts